EMAIL THIS PAGE TO A FRIEND

Molecular medicine (Cambridge, Mass.)

Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.


PMID 25105301

Abstract

Lapatinib, a tyrosine kinase inhibitor, is used in the treatment of advanced or metastatic breast cancer overexpressing human epidermal receptor 2 (HER2). Lapatinib can modulate the function of ATP-binding cassette (ABC) transporters (ABCB1 and ABCG2), which are the major mechanism responsible for multidrug resistance (MDR) in cancer. In this study, we investigated the effect of lapatinib on multidrug resistance-associated protein 1 (MRP1 [ABCC1]), MRP2 (ABCC2), MRP4 (ABCC4) and lung relative resistance protein (LRP) drug efflux pumps. We demonstrated that lapatinib could enhance the efficacy of conventional chemotherapeutic agents in MRP1-overexpressing cells in vitro and in vivo, but no effect in MRP2-, MPR4- and LRP-overexpressing cells. Furthermore, lapatinib significantly increased the accumulation of rhodamine 123 (Rho123) and doxorubicin (DOX) in MRP1-overexpressing cells. However, lapatinib did not alter the protein or mRNA expression levels of MRP1. Further studies showed that the level of phosphorylation of AKT and extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) were not altered at the indicated concentrations of lapatinib. In conclusion, lapatinib enhanced the efficacy of conventional chemotherapeutic agents in MRP1-overexpressing cells by inhibiting MRP1 transport function without altering the level of AKT or ERK1/2 phosphorylation. These findings will encourage the clinical research of lapatinib combined with conventional chemotherapeutic drugs in MRP1-overexpressing cancer patients.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2500010
Anti-ABCC1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA002380
Anti-ABCC1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
SAB2100010
Anti-ABCC1 antibody produced in rabbit, affinity isolated antibody
SAB1406114
Anti-MDM4 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV06007
Anti-MDM4 antibody produced in rabbit, affinity isolated antibody
HPA018919 Anti-MDM4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4501852
Anti-MDM4 antibody produced in rabbit, affinity isolated antibody
SAB2103899
Anti-MDM4, (N-terminal) antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB1300711
Anti-MSH3 (center) antibody produced in rabbit, saturated ammonium sulfate (SAS) precipitated, buffered aqueous solution
M0445
Monoclonal Anti-MDMX antibody produced in mouse, clone MDMX-82, purified from hybridoma cell culture
M9067
Monoclonal Anti-MRP1 antibody produced in mouse, ~2 mg/mL, clone QCRL-1, purified immunoglobulin, buffered aqueous solution
M9192 Monoclonal Anti-MRP1 antibody produced in mouse, ~2 mg/mL, clone QCRL-4, purified immunoglobulin, buffered aqueous solution